Lakshmikumaran and Sridharan advises Krsnaa Diagnostics on stake purchase in Apulki Healthcare

Krsnaa Diagnostics Limited has acquired 23.35% stake in Apulki Healthcare Private Limited.

Lakshmikumaran and Sridharan advised Krsnaa Diagnostics on this stake acquisition deal. The Firm’s role included conducting legal due diligence on Apulki, drafting and review of transaction documents, and strategic advisory on tax implications.

The transaction team was led by Noorul Hassan (Partner) along with Shipra Verma (Principal Associate) and Kumar Panda (Principal Associate).

Direct tax advisory was provided by Sudin Sabnis (Partner), Lokesh Gandhi (Associate) and Deah Kapoor (Consultant).

The corporate due diligence team consisted of Noorul Hassan (Partner), Shipra Verma (Principal Associate), Aishwarya Narasimhan (Associate) and Krishna Chandak (Consultant).

Additionally, Sameer Avasarala (Principal Associate) and Aryashree Kunhambu (Associate) assisted with intellectual property and data protection aspects of the due diligence.

Apulki specialises in operating cancer and cardiac care hospitals in public-private partnership (PPP) mode.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.